Effect of LANCONONE in Weight-bearing Joint Pain
Not Applicable
Completed
- Conditions
- Osteo Arthritis Knee
- Interventions
- Dietary Supplement: Lanconone®Dietary Supplement: Methyl crystalline cellulose
- Registration Number
- NCT03658369
- Lead Sponsor
- Vedic Lifesciences Pvt. Ltd.
- Brief Summary
The current study has been designed to primarily assess the effect of Lanconone® in comparison to placebo on pain in weight bearing joints.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 72
Inclusion Criteria
- BMI ≥ 25 and ≤ 29.9 kg/m2.
- With unilateral or bilateral OA of the knee for at least greater than 3 months, as presented by pain in the knee at least for last 3 months.
- Post-menopausal females (LMP at least 12 months prior to the screening).
Exclusion Criteria
- History of osteoarthritis for more than 3 years.
- Systolic Blood Pressure ≥140 mm Hg and Diastolic Blood Pressure ≥ 90 mm Hg
- FBS>140 mg/dl.
- Smokers or chronic alcoholics.
- Participants planning to travel in the next 56 days or engage in any non-routine activity that is likely to strain the knees.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Lanconone® Lanconone® Lanconone®: 2 Capsules once a day after breakfast Methyl Crystalline Cellulose Methyl crystalline cellulose 2 Capsules once a day after breakfast
- Primary Outcome Measures
Name Time Method WOMAC (Western Ontario and McMaster universities Osteoarthritis Index) pain score 56 days Change in pain score.The score ranges from 0-5, wherein 0 indicates no pain and 5 indicates extreme pain.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (4)
K.K Medical Centre
🇮🇳Mumbai, Maharashtra, India
Siddhant Clinic
🇮🇳Mumbai, Maharashtra, India
Ayush Nursing Home
🇮🇳Mumbai, Maharashtra, India
Dinanath Nursing Home
🇮🇳Mumbai, Maharashtra, India